Persistence Market Research is released new forthcoming report on title "H1N1 Vaccines Market: Global Industry Analysis and Forecast to 2020".
New York, NY -- (SBWIRE) -- 11/19/2014 -- A vaccine is a biological preparation that contains an agent that resembles a disease-causing microorganism and is made from weakened and killed forms of microorganisms. Vaccines can be categorized into many types such as inactivated vaccines, attenuated vaccines, toxoid and conjugate. Cholera, influenza, hepatitis A, polio and rabies vaccines are inactivated vaccines. The global vaccines market is categorized on the basis of different diseases to be treated. Various diseases that are treated using H1N1 vaccines include influenza, meningococcal, cervical cancer, pneumococcal, hepatitis, measles, mumps, rubella and others. H1N1 vaccines refer to the medical preparation for treatment of swine flu. H1N1 influenza is an infectious disease whose causative agent is a variant of the swine H1N1 virus. H1N1 virus is an RNA virus belonging to the orthomyxoviridae family and infects nose lungs and throat. In addition to humans, this virus may infect different animal species such as birds, swine, horses and others. On the basis of its surface composition, H1N1 virus can be classified into neuraminidase and hemagglutinin. Hemagglutinin is used by the virus to bind to host cell receptors and allow the entry of virus into the host cell. H1N1 vaccines market is growing at a significant rate due to rise in elderly population which is prone to such infectious diseases. In addition, rise in prevalence of chronic diseases such as lung disease, asthma, neurological disorders and others. In addition, technological advancements in the field are driving the global market for H1N1 vaccines.
Buy Full Report:
North America and Europe dominates the global H1N1 vaccines market. This is due to improved research infrastructure in these regions. The U.S. represents the largest market for H1N1 vaccines followed by Canada in North America. In Europe, France and Germany holds major share of H1N1 vaccines market. However, Asia is expected to show high growth rates in the next five years in the global H1N1 vaccines market due to increasing awareness among people about preventable diseases. Several government associations have launched various programs to raise awareness among people towards various infectious diseases, in Asia. This has resulted in significant rise in demand of H1N1 vaccines for the prevention of swine flu. In addition, many companies constructing their manufacturing and research facilities in the developing regions. This is due to low wages, availability of a large talent pool, less stringent environment and health and safety regulations in the region. Japan, China and India are expected to be the fastest growing H1N1 vaccines markets in Asia.
In recent time, increasing prevalence of swine flu cases and novel vaccine technologies are some of the major drivers for the global H1N1 vaccines market. In addition, increased research in the field of vaccine technologies and increasing government supports are driving the global H1N1 vaccines market. However, factors such as less awareness and lack of experienced medical professionals are restraining the growth of H1N1 vaccines market. In addition, high capital requirement and stringent regulations are restraining the global market for H1N1 vaccines.
Growing demographics and economies in the developing countries such as India and China are expected to offer good opportunities for H1N1 vaccines market. Innovation of some new products with focus on better efficiency is expected to offer good opportunity for the global H1N1 vaccines market. Advancement in biomedical science would develop opportunity for global H1N1 vaccines market. Increasing mergers and collaborations between manufacturing companies and government associations and rapid product launches are some of the major trends of the global H1N1 vaccines market. Some of the major companies dealing in the global H1N1 vaccines market are Medimmune, GlaxoSmithKline, Novartis and Sanofi Pastuer. Some other companies having significant presence in the global H1N1 vaccines market are Commonwealth Serum Laboratories (CSL), Sinovac and Baxter.
Request Full Toc:
About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.